Dissecting the steps in early simian immunodeficiency virus dissemination following mucosal and intravenous infection of rhesus macaques
Steffen S. Docken, Agatha Macairan, Timothy E. Schlub, Christine M. Fennessey, Benjamin Varco-Merth, Louis J. Picker, Afam A. Okoye, Taina T. Immonen, Deborah Cromer, Brandon F. Keele, Miles P. Davenport

TL;DR
This study tracks how simian immunodeficiency virus spreads early in rhesus macaques, revealing bottlenecks and variability in viral growth.
Contribution
The study introduces a barcoded SIV model to dissect early dissemination bottlenecks and lineage heterogeneity in vivo.
Findings
Lineage heterogeneity is similar after mucosal and intravenous infection.
Early cellular infection events account for 23%–44% of dissemination bottleneck variability.
Anatomical site differences likely explain 56%–77% of viral spread heterogeneity.
Abstract
Early HIV infection involves the transmission of a small number of virions and the subsequent expansion and spread of the virus. The early phases of infection represent an important opportunity for viral control, although relatively little is understood about the determinants of the rate of spread or the “bottlenecks” the virus must negotiate during this time. Here, we use the barcoded simian immunodeficiency virus (SIV) infection model to analyze the kinetics of early SIV infection in vitro and in vivo. We analyze the trajectories of multiple individual barcode lineages across in vitro infection of cell lines and primary cells and after mucosal and intravenous infection of macaques. We observe a large distribution in lineage sizes when an infection is founded by multiple different viral lineages, which we presume results from bottleneck-induced variability in early growth between…
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12
Figure 13
Figure 14
Figure 15
Figure 16
Figure 17
Figure 18
Figure 19
Figure 20
Figure 21
Figure 22
Figure 23
Figure 24
Figure 25
Figure 26
Figure 27
Figure 28
Figure 29
Figure 30
Figure 31
Figure 32
Figure 33
Figure 34
Figure 35
Figure 36
Figure 37
Figure 38
Figure 39
Figure 40
Figure 41
Figure 42
Figure 43
Figure 44
Figure 45
Figure 46
Figure 47
Figure 48
Figure 49
Figure 50Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsHIV Research and Treatment · HIV/AIDS drug development and treatment · HIV/AIDS Research and Interventions
